Marex Group’s Fractyl Health GUTS Stock Holding History

Marex Group’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,537	Closed	-$13.5K	–	1364
2026 Q1	$13.5K	Buy	+29,537	New	+$27.2K	﹤0.01%	990

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marex Group's GUTS Position: Q2 2026 in Review

Marex Group sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 29,537 shares — an estimated $13.5K sold.

Marex Group first reported a position in GUTS in Q1 2026 and held it in 1 quarter. The position peaked at $13.5K in Q1 2026. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Marex Group reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
Marex Group sold 29,537 Fractyl Health shares in Q2 2026, an estimated $13.5K.
Marex Group first reported a position in Fractyl Health in Q1 2026 and held it in 1 quarter.
Marex Group's Fractyl Health position peaked at $13.5K in Q1 2026.
77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.